Literature DB >> 15857554

Scope and epidemiology of pediatric sepsis.

R Scott Watson1, Joseph A Carcillo.   

Abstract

OBJECTIVE: To summarize the scope and epidemiology of pediatric sepsis.
DESIGN: Review of published literature.
RESULTS: Sepsis is a leading cause of death in infants and children, with >42,000 cases of severe sepsis annually in the United States and millions worldwide. Half of the children with severe sepsis in the United States are infants, and half of infants are low- or very low-birth-weight babies. Underlying disease occurs in 49% of U.S. children with severe sepsis. National hospital costs associated with severe sepsis in the United States were $2.3 billion in 1999. Relatively simple strategies to identify and treat children with sepsis in the developing world have shown remarkable success. These strategies have included empirical antibiotics in babies at high risk of sepsis and aggressive fluid resuscitation in Dengue hemorrhagic fever.
CONCLUSIONS: Sepsis is a major health problem among children in both developing and industrialized countries. However, sepsis is both preventable and treatable. Improved prevention and treatment of sepsis could have a substantial effect on survival and quality of life of all children, both those who are otherwise healthy and those who are chronically ill. The variations in the epidemiology of pediatric sepsis underscore the need for a multidisciplinary approach and consistently applied definitions.

Entities:  

Mesh:

Year:  2005        PMID: 15857554     DOI: 10.1097/01.PCC.0000161289.22464.C3

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  86 in total

1.  Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury.

Authors:  Kathryn A Seely; Joseph H Holthoff; Samuel T Burns; Zhen Wang; Keshari M Thakali; Neriman Gokden; Sung W Rhee; Philip R Mayeux
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

2.  Neonatal sepsis and neutrophil insufficiencies.

Authors:  John Nicholas Melvan; Gregory J Bagby; David A Welsh; Steve Nelson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2010-06       Impact factor: 5.311

3.  Comparison of Methods for Identification of Pediatric Severe Sepsis and Septic Shock in the Virtual Pediatric Systems Database.

Authors:  Robert B Lindell; Akira Nishisaki; Scott L Weiss; Fran Balamuth; Danielle M Traynor; Marianne R Chilutti; Robert W Grundmeier; Julie C Fitzgerald
Journal:  Crit Care Med       Date:  2019-02       Impact factor: 7.598

Review 4.  Metabolomics as a Driver in Advancing Precision Medicine in Sepsis.

Authors:  Michelle Eckerle; Lilliam Ambroggio; Michael A Puskarich; Brent Winston; Alan E Jones; Theodore J Standiford; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2017-07-31       Impact factor: 4.705

5.  Cell wall-mediated neuronal damage in early sepsis.

Authors:  Carlos J Orihuela; Sophie Fillon; S Hope Smith-Sielicki; Karim C El Kasmi; Geli Gao; Konstantinos Soulis; Avinash Patil; Peter J Murray; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum.

Authors:  Hector R Wong; Natalie Cvijanovich; Geoffrey L Allen; Richard Lin; Nick Anas; Keith Meyer; Robert J Freishtat; Marie Monaco; Kelli Odoms; Bhuvaneswari Sakthivel; Thomas P Shanley
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

Review 7.  The Economic and Humanistic Burden of Severe Sepsis.

Authors:  Bogdan Tiru; Ernest K DiNino; Abigail Orenstein; Patrick T Mailloux; Adam Pesaturo; Abhinav Gupta; William T McGee
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

8.  Venoarterial extracorporeal membrane oxygenation support for neonatal and pediatric refractory septic shock: more than 15 years of learning.

Authors:  Anna Solé; Iolanda Jordan; Sara Bobillo; Julio Moreno; Monica Balaguer; Lluisa Hernández-Platero; Susana Segura; Francisco José Cambra; Elisabeth Esteban; Javier Rodríguez-Fanjul
Journal:  Eur J Pediatr       Date:  2018-05-24       Impact factor: 3.183

Review 9.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

Review 10.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.